EPN — Epsilon Healthcare Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual income statement for Epsilon Healthcare, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.79 | 6.95 | 5.5 | 4.65 | 6.65 |
| Cost of Revenue | |||||
| Gross Profit | 1.07 | 2.34 | 1.92 | 1.24 | 4.81 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16.6 | 17.7 | 17.2 | 19.8 | 9.47 |
| Operating Profit | -11.8 | -10.8 | -11.7 | -15.1 | -2.82 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.7 | -10.5 | -10.1 | -14.1 | -3.31 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.7 | -10.5 | -9.24 | -13.6 | -1.09 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.7 | -10.5 | -9.24 | -13.6 | -1.09 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.7 | -10.5 | -9.24 | -13.6 | -1.09 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.073 | -0.066 | -0.039 | -0.026 | -0.003 |